Este medicamento es principalmente un antidiabtico, cuyo objetivo es controlar los niveles de glucosa en sangre en pacientes con diabetes tipo 2, detall Caldern
However, if the liver is sluggish or overwhelmed, the body may turn to the skin as a secondary exit point for waste
SGLT2 inhibitors is the ability of these medications to enhance the activity of incretin hormones (that is, GLP-1 and glucose-dependent insulinotropic polypeptide), delaying gastric emptying and reducing gastrointestinal motility, Alkabbani and colleagues explained
This approval is for adults who are obese, with a body mass index (BMI) of 30 kg/m2 or higher, or overweight, with a BMI of 27 kg/m2 or higher, and who also have at least one weight-related health condition such as high blood pressure, type 2 diabetes, or high cholesterol